Atlas Trials

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Clinical trial NCT00654745 · COMPLETED

Trial details

NCT number
NCT00654745
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesHypertension
Start date
2008-05-01
Primary completion
2009-04-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.